Skip to main content

Terra µBiomic

Broad-Spectrum SBO Probiotic

Soil-based organism (SBO) probiotic designed to reset the gut microbiome, enhance biodiversity, improve digestion, maintain the gut lining, and reduce pathogenic microbes.

  • Gut

    Gut

  • Detox

    Detox

  • Immunity

    Immunity

  • Whole Body

    Whole Body

Health Indications

  • Alleviate Diarrhea
  • Diversify the Microbiome
  • Reduce Side-Effects of Antibiotics
  • Ease Allergy Symptoms
  • Fight Pathogens (Harmful Bacteria) and Their Toxins
  • Support Healthy Digestive Function
  • Support Healthy Bowel Transit Time
  • Reduce Occasional Constipation, Gas and Bloating

Instructions For Use

Take 1-2 capsules daily for 30 days with or without food. Refrigerate after opening to optimize shelf life.

We recommend that Terra µBiomic be paired with its synergistic prebiotic formula, Terra Superfood, for unparalleled results and remarkable health benefits.

**Individual needs may vary; please consult your practitioner before altering the prescribed doses or protocols.

Product Description

Terra µBiomic - Product Description

Soil-based probiotics are friendly bacteria found in the soil that have evolved alongside humans. There are over 100 types of beneficial soil-based probiotics naturally occurring in the soil. In the past, people had daily contact with these bacteria through activities like farming and hunting. Nowadays, our natural exposure to these probiotics is very limited.

Historically, humans have had a strong connection with the earth, sourcing their food from the land and not relying on disinfectants or pesticides. However, in modern times, soil-based probiotics are rare in our diets unless we grow our own food or eat fresh, organic produce straight from the ground. Due to the long history of interaction between humans and these microbes, soil-based probiotics can play a significant role in shaping the gut microbiome. The microbiome is a community of microorganisms in your digestive system that impacts every facet of your overall well-being.

Terra µBiomic - Product Description

Consuming these probiotics can help compensate for the reduced contact we now have with natural environments and dirt. What sets them apart is their ability to release spores protected by a tough shell, which is why they are also sometimes called ‘spore-forming bacteria.’ This shell allows them to survive the acidity of the stomach and the digestive enzymes that would normally harm other probiotics. This resilience ensures that they reach the colon, where they are most effective, unharmed and ready to provide their beneficial effects.

These soil-based organisms are especially good at producing enzymes, antimicrobial peptides, and possess unique detox abilities. Their ability to break down substances, produce important gut healing compounds, and fight harmful pathogens such as foreign bacteria, mold, yeast, and parasites are what makes SBO probiotic species special. They are an especially good place to start when looking to heal a damaged intestinal lining like leaky gut,1 correct digestive issues related to pathogens, or address an unhealthy microbiome. SBO probiotics are essential when starting any type of detox, purge, or intestinal reset protocol.

Key Elements and Features of Terra µBiomic

  • Purge Pathogens

    SBOs act as a biological defense force by producing antimicrobial substances, enhancing the body’s ability to fend off pathogens like bacteria, mold, fungus, yeast and parasites. Their resilience in harsh conditions makes them adept at maintaining a healthy balance in the face of microbial challenges. Incorporating soil-based organisms into the microbiome fortifies the body’s natural defenses against a full spectrum of pathogens to promote optimal health.

  • Heal the Gut Lining

    Soil-based organisms (SBOs) exhibit unique properties that contribute to the healing of the intestinal lining, which is particularly beneficial for conditions like leaky gut. These microorganisms produce bioactive compounds and enzymes that support the restoration of gut integrity.

  • Detox and Drainage

    Soil-based organisms (SBOs) play a vital role in detoxification by producing unique enzymes that break down and eliminate toxins. They effectively bind and capture toxins, heavy metals, and harmful substances in the intestinal tract, contributing to the body’s natural detox pathways. This helps reduce toxin exposure, supporting optimal genetic expression and metabolic functions. Additionally, SBOs optimize the drainage pathway of the colon, ensuring proper digestive functions. By capturing die-off, toxins, and excess waste hormones, they facilitate the excretion of these substances, promoting overall well-being.

  • Digestive Function and Transit Times

    Soil-based organisms (SBOs) produce specialized enzymes that specifically target and break down a diverse range of food and food allergens. This not only enhances the digestive process but also facilitates improved nutrient absorption. By effectively addressing unique food allergens, SBOs play a crucial role in optimizing digestive function. Additionally, these organisms promote a balanced composition of gut bacteria, ensuring ideal transit times for food within the digestive system. In doing so, SBOs support the body in efficiently extracting essential elements from the diet, thereby enhancing overall digestive efficiency.

  • Guaranteed Viability

    Soil-based organisms (SBOs) possess a remarkable resilience that allows them to endure the harsh conditions of the gastrointestinal tract. These hardy microorganisms have evolved mechanisms to withstand the acidic environment of the stomach, enabling them to reach the intestines intact where they exert their beneficial effects.

Probiotic Spotlight

SBO probiotics are believed to closely mimic the ancestral environment in which humans evolved, where exposure to diverse microorganisms in the soil played a crucial role in shaping the gut immune system and overall health. This connection to the natural environment suggests that SBO probiotics offer a more holistic approach to microbiome support.

By introducing these unique strains that are adapted to thrive in soil, SBO probiotics contribute to the overall function of the gut and its microbiome on top of what is commonly offered by conventional probiotic supplements.

This is not to say that conventional probiotics are not also beneficial. We recommend them, as they are essential and provide their own unique health benefits. However, we highly recommend starting with SBO probiotics to reset the gut microbiome and heal the gut lining first. Then, introduce our other prebiotic and probiotic systems directly after.

How Terra µBiomic Works

SBOs promote a balanced gut microbiome, enhance digestion, support immune health, stabilize gut pH, have a strong ability to combat harmful bacteria, and contribute to the production of short-chain fatty acids.

How It Works

Key Ingredients

Weizmannia coagulans (Bacillus coagulans)

Weizmannia coagulans (previously known as Bacillus coagulans) is the most studied soil-based probiotic. It is a spore-forming probiotic that produces lactic acid and helps alleviate symptoms and complications associated with irritable bowel syndrome (IBS).2–7 W. coagulans can also inhibit the growth of harmful bacteria.2,7 Additionally, it can synthesize specific vitamins like B1, B2, B3, B6, and B12, while producing various enzymes (e.g., amylases, proteases, and lipases) that assist in digesting carbohydrates, proteins, and fats.3,8,9 Furthermore, certain metabolites generated by W. coagulans possess antioxidant properties, contributing to the reduction of oxidative stress and in turn, promoting gut repair.2,3 Studies have shown that W. coagulans has a positive effect on gastrointestinal issues like diarrhea, bloating, abdominal pain, small intestinal bacterial overgrowth (SIBO), and constipation.3,4,10,11

Bacillus pumilus

B. pumilus is an aerobic, spore-forming probiotic commonly found in the soil, known for its high resistance to environmental stresses. It is highly efficient at producing antimicrobial fungal compounds that support the elimination of pathogenic mold and yeast.12,13 Additionally, B. pumilus produces two strong antioxidant compounds: riboflavin (vitamin B2) and C30 carotenoids.14

Alkalihalobacillus clausii

Also known as Bacillus clausii, A. clausii inhibits the growth of various pathogens and opportunistic pathogens by producing antimicrobial compounds,15–17 in addition to synthesizing the potent antioxidant riboflavin, also known as the essential vitamin B2.16 A. clausii has been shown to modulate both the pro- and anti-inflammatory balance of the gut.17,18 It is also known to reduce the duration of diarrheal illness and help control small intestinal bacterial overgrowth (SIBO).17

Bacillus licheniformis

The spores of B. licheniformis are able to withstand the presence of bile salts and low gastric pH, allowing them to reach the gut intact. This soil-based probiotic produces a wide range of digestive enzymes, antimicrobials, and organic acids that help heal and manage the gut lining while regulating the microbiome.19,20 B. licheniformis has also shown promise in weight control and improved glucose tolerance.21

Bacillus amyloliquefaciens

Bacillus amyloliquefaciens is known for its metabolic diversity that allows it to produce a wide range of compounds with antioxidant, antimicrobial, and anti-inflammatory properties, while also inhibiting biofilm formation by pathogenic bacteria, making it a valuable microorganism for potential health applications.22–24

Bacillus megaterium

Also known as Priestia megaterium, research shows that this probiotic increases the activity of digestive enzymes and enzyme production.25 B. megaterium produces mannitol and C30 carotenoids, which help reduce oxidative stress in the gut. This powerful antioxidant action promotes the growth of the Faecalibacterium prausnitzii, a highly beneficial keystone probiotic that is also found in Alimentum Labs’ Neuro μBiomic.14

Paenibacillus mucilaginosus

Also known as Bacillus mucilaginosus, this probiotic is typically found in the soil and provides dynamic support to the digestive system. P. mucilaginosus produces a bacteriocin that inhibits the growth of opportunistic pathogens, such as Clostridioides difficile.26 It also produces exopolysaccharides (EPS) that have been shown to provide immunomodulatory effects.27

Bacillus subtilis

Among Bacillus bacteria, B. subtilis is the species that produces the most antimicrobial compounds to fight off harmful bacteria in the microbiome.28–30 Research shows these probiotics also possess strong properties that promote healthy inflammatory responses in the intestine and strengthen the gut barrier.31 B. subtilis has a unique ability to produce a potent antiviral peptide called P18 that can help provide protection against viral pathogens.32 It is also an excellent producer of proteolytic enzymes (proteases) that assist in breaking down proteins during digestion, or biofilms on an empty stomach.29,30 Furthermore, it shows potential in reducing inflammation in the intestinal tract.33

Bacillus indicus

A very hardy spore-forming bacterium that thrives in the harsh conditions of the digestive tract34,35, B. indicus produces antioxidant and anti-inflammatory compounds, such as xanthorhamnin and carotenoids.34,36 It is also capable of forming biofilms that can inhibit the growth of pathogens and interact with the host immune system.37

Brevibacillus laterosporus

Research shows that the B. laterosporus species, (previously known as Bacillus laterosporus) in particular, exhibits a wide variety of antimicrobial features. Consequently, it plays a crucial role in maintaining a healthy GI tract by protecting the microbiome from human pathogens and food spoilage microbes.38–40

Paenibacillus polymyxa

Recent research shows that this probiotic assists in controlling pathogenic microorganisms through the secretion of antimicrobial compounds.41,42 Additionally, P. polymyxa has demonstrated antioxidant and immune-stimulating properties.42

Kefir

While it has been consumed for centuries, ongoing research continues to report numerous benefits associated with its consumption. These include antimicrobial activity against human pathogens and some promising evidence suggesting that it may have the potential to improve lactose intolerance. As a mesophilic symbiotic culture, kefir serves a dual role as both a probiotic and a unique prebiotic food source for bacteria.43

Kombucha SCOBY

Enhances gut health and supports a normal immune system response. Research shows that the drink is characterized by a high content of bioactive compounds that provide strong antioxidant and antimicrobial properties.44

Warnings/Contraindications

When used as directed there are no contraindications for Terra μBiomic.

**It is always recommended that you consult your practitioner prior to adding any new supplement to your regimen if you are pregnant, breastfeeding, experiencing renal failure, undergoing an organ transplant(s), managing diabetes with insulin, or are taking medication(s) for any pre-existing conditions.**

Safety

All ingredients are tested before use for:

  • Pathogenic microbial contaminants
  • Heavy metals and/or chemical contaminants
  • Correct genus and species of probiotic microbes
  • Purity

Additional Information

  • Gluten Free
  • Dairy Free
  • Vegan
  • No Sugar
  • Non-GMO
  • cGMP Facility
  • No Egg

References

  1. McFarlin, B. K.; Henning, A. L.; Bowman, E. M.; Gary, M. A.; Carbajal, K. M. Oral Spore-Based Probiotic Supplementation Was Associated with Reduced Incidence of Post-Prandial Dietary Endotoxin, Triglycerides, and Disease Risk Biomarkers. World J. Gastrointest. Pathophysiol. 2017, 8 (3), 117–126. https://doi.org/10.4291/wjgp.v8.i3.117.
  2. Konuray, G.; Erginkaya, Z. Potential Use of Bacillus Coagulans in the Food Industry. Foods 2018, 7 (6), 92. https://doi.org/10.3390/foods7060092.
  3. Cao, J.; Yu, Z.; Liu, W.; Zhao, J.; Zhang, H.; Zhai, Q.; Chen, W. Probiotic Characteristics of Bacillus Coagulans and Associated Implications for Human Health and Diseases. J. Funct. Foods 2020, 64, 103643. https://doi.org/10.1016/j.jff.2019.103643.
  4. Majeed, M.; Nagabhushanam, K.; Arumugam, S.; Majeed, S.; Ali, F. Bacillus Coagulans MTCC 5856 for the Management of Major Depression with Irritable Bowel Syndrome: A Randomised, Doubleblind, Placebo Controlled, Multi-Centre, Pilot Clinical Study. Food Nutr. Res. 2018. https://doi.org/10.29219/fnr.v62.1218.
  5. Dolin, B.J. Effects of a Proprietary Bacillus Coagulans Preparation on Symptoms of Diarrhea-Predominant Irritable Bowel Syndrome. Methods Find. Exp. Clin. Pharmacol. 2009, 31 (10), 655. https://doi.org/10.1358/mf.2009.31.10.1441078.
  6. Rogha, M.; Esfahani, M. Z.; Zargarzadeh, A. H. The Efficacy of a Synbiotic Containing Bacillus Coagulans in Treatment of Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Gastroenterol. Hepatol. Bed Bench 2014, 7 (3), 156–163.
  7. Abdhul, K.; Ganesh, M.; Shanmughapriya, S.; Vanithamani, S.; Kanagavel, M.; Anbarasu, K.; Natarajaseenivasan, K. Bacteriocinogenic Potential of a Probiotic Strain Bacillus Coagulans [BDU3] from Ngari. Int. J. Biol. Macromol. 2015, 79, 800–806. https://doi.org/10.1016/j.ijbiomac.2015.06.005.
  8. Keating, L. A.; Kelly, C. T.; Fogarty, W. M. The α-Amylase of Bacillus Coagulans. Biochem. Soc. Trans. 1996, 24 (1), 44S-44S. https://doi.org/10.1042/bst024044s.
  9. Perkins, J. B.; Pero, J. G. Biosynthesis of Riboflavin, Biotin, Folic Acid, and Cobalamin. In Bacillus subtilis and Other Gram-Positive Bacteria; John Wiley & Sons, Ltd, 1993; pp 319–334. https://doi.org/10.1128/9781555818388.ch23.
  10. Ratna Sudha, M.; Yelikar, K. A.; Deshpande, S. Clinical Study of Bacilluscoagulans Unique IS-2 (ATCC PTA-11748) in the Treatment of Patients with Bacterial Vaginosis. Indian J. Microbiol. 2012, 52 (3), 396–399. https://doi.org/10.1007/s12088-011-0233-z.
  11. Khalighi, A. R.; Khalighi, M. R.; Behdani, R.; Jamali, J.; Khosravi, A.; Kouhestani, S.; Radmanesh, H.; Esmaeelzadeh, S.; Khalighi, N. Evaluating the Efficacy of Probiotic on Treatment in Patients with Small Intestinal Bacterial Overgrowth (SIBO) – A Pilot Study. Indian J. Med. Res. 2014, 140 (5), 604.
  12. Saggese, A.; Culurciello, R.; Casillo, A.; Corsaro, M. M.; Ricca, E.; Baccigalupi, L. A Marine Isolate of Bacillus Pumilus Secretes a Pumilacidin Active against Staphylococcus Aureus. Mar. Drugs 2018, 16 (6), 180. https://doi.org/10.3390/md16060180.
  13. Cycoń, M.; Mrozik, A.; Piotrowska-Seget, Z. Antibiotics in the Soil Environment—Degradation and Their Impact on Microbial Activity and Diversity. Front. Microbiol. 2019, 10. https://doi.org/10.3389/fmicb.2019.00338.
  14. Kotowicz, N.; Bhardwaj, R. k.; Ferreira, W. t.; Hong, H. a.; Olender, A.; Ramirez, J.; Cutting, S. m. Safety and Probiotic Evaluation of Two Bacillus Strains Producing Antioxidant Compounds. Benef. Microbes 2019, 10 (7), 759–771. https://doi.org/10.3920/BM2019.0040.
  15. Ianiro, G.; Rizzatti, G.; Plomer, M.; Lopetuso, L.; Scaldaferri, F.; Franceschi, F.; Cammarota, G.; Gasbarrini, A. Bacillus Clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2018, 10 (8), 1074. https://doi.org/10.3390/nu10081074.
  16. Ghelardi, E.; Abreu y Abreu, A. T.; Marzet, C. B.; Álvarez Calatayud, G.; Perez, M.; Moschione Castro, A. P. Current Progress and Future Perspectives on the Use of Bacillus Clausii. Microorganisms 2022, 10 (6), 1246. https://doi.org/10.3390/microorganisms10061246.
  17. Lopetuso, L. R.; Scaldaferri, F.; Franceschi, F.; Gasbarrini, A. Bacillus Clausii and Gut Homeostasis: State of the Art and Future Perspectives. Expert Rev. Gastroenterol. Hepatol. 2016, 10 (8), 943–948. https://doi.org/10.1080/17474124.2016.1200465.
  18. Paparo, L.; Tripodi, L.; Bruno, C.; Pisapia, L.; Damiano, C.; Pastore, L.; Berni Canani, R. Protective Action of Bacillus Clausii Probiotic Strains in an in Vitro Model of Rotavirus Infection. Sci. Rep. 2020, 10 (1), 12636. https://doi.org/10.1038/s41598-020-69533-7.
  19. Muras, A.; Romero, M.; Mayer, C.; Otero, A. Biotechnological Applications of Bacillus Licheniformis. Crit. Rev. Biotechnol. 2021, 41 (4), 609–627. https://doi.org/10.1080/07388551.2021.1873239.
  20. Mahajan, R. V.; Kumar, V.; Rajendran, V.; Saran, S.; Ghosh, P. C.; Saxena, R. K. Purification and Characterization of a Novel and Robust L-Asparaginase Having Low-Glutaminase Activity from Bacillus Licheniformis: In Vitro Evaluation of Anti-Cancerous Properties. PLOS ONE 2014, 9 (6), e99037. https://doi.org/10.1371/journal.pone.0099037.
  21. Cao, G. T.; Dai, B.; Wang, K. L.; Yan, Y.; Xu, Y. L.; Wang, Y. X.; Yang, C. M. Bacillus Licheniformis, a Potential Probiotic, Inhibits Obesity by Modulating Colonic Microflora in C57BL/6J Mice Model. J. Appl. Microbiol. 2019, 127 (3), 880–888. https://doi.org/10.1111/jam.14352.
  22. WoldemariamYohannes, K.; Wan, Z.; Yu, Q.; Li, H.; Wei, X.; Liu, Y.; Wang, J.; Sun, B. Prebiotic, Probiotic, Antimicrobial, and Functional Food Applications of Bacillus Amyloliquefaciens. J. Agric. Food Chem. 2020, 68 (50), 14709–14727. https://doi.org/10.1021/acs.jafc.0c06396.
  23. Algburi, A.; Alazzawi, S. A.; Al-Ezzy, A. I. A.; Weeks, R.; Chistyakov, V.; Chikindas, M. L. Potential Probiotics Bacillus Subtilis KATMIRA1933 and Bacillus Amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus Mirabilis and Prevent Biofilm Formation. Probiotics Antimicrob. Proteins 2020, 12 (4), 1471–1483. https://doi.org/10.1007/s12602-020-09631-0.
  24. Jeong, S.-Y.; Jeong, D. Y.; Kim, D. S.; Park, S. Chungkookjang with High Contents of Poly-γ-Glutamic Acid Improves Insulin Sensitizing Activity in Adipocytes and Neuronal Cells. Nutrients 2018, 10 (11), 1588. https://doi.org/10.3390/nu10111588.
  25. Vary, P. S.; Biedendieck, R.; Fuerch, T.; Meinhardt, F.; Rohde, M.; Deckwer, W.-D.; Jahn, D. Bacillus Megaterium–from Simple Soil Bacterium to Industrial Protein Production Host. Appl. Microbiol. Biotechnol. 2007, 76 (5), 957–967. https://doi.org/10.1007/s00253-007-1089-3.
  26. Liu, J.; Liu, Y.; Lv, H.; Liu, Q.; Li, M. [Research progress in human symbiotic bacteria and their antibacterial molecules]. Sheng Wu Gong Cheng Xue Bao Chin. J. Biotechnol. 2018, 34 (8), 1316–1325. https://doi.org/10.13345/j.cjb.170520.
  27. Yu, L.; Xu, X.; Zhou, J.; Lv, G.; Chen, J. Chain Conformation and Rheological Behavior of Exopolysaccharide from Bacillus Mucilaginosus SM-01. Food Hydrocoll. 2017, 65, 165–174. https://doi.org/10.1016/j.foodhyd.2016.11.013.
  28. Yahav, S.; Berkovich, Z.; Ostrov, I.; Reifen, R.; Shemesh, M. Encapsulation of Beneficial Probiotic Bacteria in Extracellular Matrix from Biofilm-Forming Bacillus Subtilis. Artif. Cells Nanomedicine Biotechnol. 2018, 46 (sup2), 974–982. https://doi.org/10.1080/21691401.2018.1476373.
  29. Erega, A.; Stefanic, P.; Dogsa, I.; Danevčič, T.; Simunovic, K.; Klančnik, A.; Smole Možina, S.; Mandic Mulec, I. Bacillaene Mediates the Inhibitory Effect of Bacillus Subtilis on Campylobacter Jejuni Biofilms. Appl. Environ. Microbiol. 2021, 87 (12), e02955-20. https://doi.org/10.1128/AEM.02955-20.
  30. Kimelman, H.; Shemesh, M. Probiotic Bifunctionality of Bacillus Subtilis—Rescuing Lactic Acid Bacteria from Desiccation and Antagonizing Pathogenic Staphylococcus Aureus. Microorganisms 2019, 7 (10), 407. https://doi.org/10.3390/microorganisms7100407.
  31. Zhang, H.; Li, W.; Xu, D.; Zheng, W.; Liu, Y.; Chen, J.; Qiu, Z.; Dorfman, R., G.; Zhang, J.; Liu, J. Mucosa-Reparing and Microbiota-Balancing Therapeutic Effect of Bacillus Subtilis Alleviates Dextrate Sulfate Sodium-Induced Ulcerative Colitis in Mice. Exp. Ther. Med. 2016, 12 (4), 2554–2562. https://doi.org/10.3892/etm.2016.3686.
  32. Starosila, D.; Rybalko, S.; Varbanetz, L.; Ivanskaya, N.; Sorokulova, I. Anti-Influenza Activity of a Bacillus Subtilis Probiotic Strain. Antimicrob. Agents Chemother. 2017, 61 (7), 10.1128/aac.00539-17. https://doi.org/10.1128/aac.00539-17.
  33. Freedman, K. E.; Hill, J. L.; Wei, Y.; Vazquez, A. R.; Grubb, D. S.; Trotter, R. E.; Wrigley, S. D.; Johnson, S. A.; Foster, M. T.; Weir, T. L. Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic Bacillus Subtilis DE111. Int. J. Mol. Sci. 2021, 22 (5), 2453. https://doi.org/10.3390/ijms22052453.
  34. Stevens, Y.; Pinheiro, I.; Salden, B.; Duysburgh, C.; Bolca, S.; Degroote, J.; Majdeddin, M.; Van Noten, N.; Gleize, B.; Caris-Veyrat, C.; Michiels, J.; Jonkers, D.; Troost, F.; Possemiers, S.; Masclee, A. Effect of a Carotenoid-Producing Bacillus Strain on Intestinal Barrier Integrity and Systemic Delivery of Carotenoids: A Randomised Trial in Animals and Humans. J. Funct. Foods 2021, 80, 104445. https://doi.org/10.1016/j.jff.2021.104445.
  35. Marzorati, M.; Van den Abbeele, P.; Bubeck, S.; Bayne, T.; Krishnan, K.; Young, A. Treatment with a Spore-Based Probiotic Containing Five Strains of Bacillus Induced Changes in the Metabolic Activity and Community Composition of the Gut Microbiota in a SHIME® Model of the Human Gastrointestinal System. Food Res. Int. 2021, 149, 110676. https://doi.org/10.1016/j.foodres.2021.110676.
  36. Chaudhri, A. A.; Nadeem, M.; Rahman, A. ur; Alam, T.; Sajjad, W.; Hasan, F.; Badshah, M.; Khan, S.; Rehman, F.; Shah, A. A. Antioxidative and Radioprotective Properties of Glycosylated Flavonoid, Xanthorhamnin from Radio-Resistant Bacterium Bacillus Indicus Strain TMC-6. Curr. Microbiol. 2020, 77 (7), 1245–1253. https://doi.org/10.1007/s00284-020-01930-7.
  37. Kawarizadeh, A.; Pourmontaseri, M.; Farzaneh, M.; Hosseinzadeh, S.; Ghaemi, M.; Tabatabaei, M.; Pourmontaseri, Z.; Pirnia, M. M. Interleukin-8 Gene Expression and Apoptosis Induced by Salmonella Typhimurium in the Presence of Bacillus Probiotics in the Epithelial Cell. J. Appl. Microbiol. 2021, 131 (1), 449–459. https://doi.org/10.1111/jam.14898.
  38. Yang, X.; Yousef, A. E. Antimicrobial Peptides Produced by Brevibacillus Spp.: Structure, Classification and Bioactivity: A Mini Review. World J. Microbiol. Biotechnol. 2018, 34 (4), 57. https://doi.org/10.1007/s11274-018-2437-4.
  39. Wu, Y.; Zhou, L.; Lu, F.; Bie, X.; Zhao, H.; Zhang, C.; Lu, Z.; Lu, Y. Discovery of a Novel Antimicrobial Lipopeptide, Brevibacillin V, from Brevibacillus Laterosporus Fmb70 and Its Application on the Preservation of Skim Milk. J. Agric. Food Chem. 2019, 67 (45), 12452–12460. https://doi.org/10.1021/acs.jafc.9b04113.
  40. Ning, Y.; Han, P.; Ma, J.; Liu, Y.; Fu, Y.; Wang, Z.; Jia, Y. Characterization of Brevilaterins, Multiple Antimicrobial Peptides Simultaneously Produced by Brevibacillus Laterosporus S62-9, and Their Application in Real Food System. Food Biosci. 2021, 42, 101091. https://doi.org/10.1016/j.fbio.2021.101091.
  41. Daud, N. S.; Mohd Din, A. R. J.; Rosli, M. A.; Azam, Z. M.; Othman, N. Z.; Sarmidi, M. R. Paenibacillus Polymyxa Bioactive Compounds for Agricultural and Biotechnological Applications. Biocatal. Agric. Biotechnol. 2019, 18, 101092. https://doi.org/10.1016/j.bcab.2019.101092.
  42. Langendries, S.; Goormachtig, S. Paenibacillus Polymyxa, a Jack of All Trades. Environ. Microbiol. 2021, 23 (10), 5659–5669. https://doi.org/10.1111/1462-2920.15450.
  43. John, S. M.; Deeseenthum, S. Properties and Benefits of Kefir -A Review. 2015.
  44. Antolak, H.; Piechota, D.; Kucharska, A. Kombucha Tea—A Double Power of Bioactive Compounds from Tea and Symbiotic Culture of Bacteria and Yeasts (SCOBY). Antioxidants 2021, 10 (10), 1541. https://doi.org/10.3390/antiox10101541.
← Back To White Paper Directory